Latest Blog Posts Tagged "Research Field News"
May 03, 2017
Researchers met to discuss the latest news in neurology and PD at the American Academy of Neurology meeting. Presenters shared results from trials of potential treatments.
March 27, 2017
A recent study showed that exercising just 2.5 hours per week could help delay decline in mobility and quality of life.
Uncovering the Promise of c-Abl as a Therapeutic Target: Testing Available Treatments and Supporting New Therapies
March 15, 2017
MJFF CEO Todd Sherer, PhD, discusses varied work happening around c-Abl inhibitors, an emerging therapeutic target that has shown early promise as a potential disease-modifying therapy.
March 09, 2017
An observational study was launched by researchers to determine how accurately smartphones can track Parkinson's symptoms.
March 08, 2017
A new study suggests that redheads may carry a gene variant that increases the risk of both Parkinson's disease and melanoma.
February 10, 2017
MJFF funded early research of this novel drug candidate, mGluR4, helping remove financial and other barriers to advance its testing.
October 26, 2016
An MJFF-funded study identified a new factor that may affect age of PD onset in individuals who carry a LRRK2 mutation.
October 11, 2016
In this podcast, MJFF staff scientist Marco Baptista, PhD, discusses the genetics and biology of LRRK2 and the role of the Foundation in advancing development of LRRK2 therapeutics.
September 08, 2016
A new study, funded in part by MJFF, identified a potential common link across different causes of Parkinson's.
September 01, 2016
MJFF-funded trial evaluating a novel therapy to treat Parkinson's disease dementia is actively recruiting.